2022 Oncology State of the Union
June 7, 2022
1:00 PM - 2:30 PMAmerica/New_York
In this year’s Oncology State of the Union, we’ll examine the most important strategic questions facing oncology leaders across the industry during the peri-Covid-19 era. While the pandemic has had very real—and at times painful—consequences already, many of the decisions that will shape the future of oncology have yet to be made. We’ll discuss which structural elements of the oncology landscape remain in flux, and what steps various oncology stakeholders can take to influence the direction and pace of change of those shifts.
Things you'll learn:
- How oncology has been impacted by the pandemic and the outlook for the future of oncology.
- Which structural elements of the oncology landscape are in flux during the peri-Covid-19 era, including the future of value-based care, site of care shift, drug costs, and more.
- What actionable steps oncology leaders across the industry can take to shape the trajectory of the major structural shifts underway right now.
Presenters: Ashley Riley and Lindsey Paul
Not a member? You can access an excerpt of the presentation here.